Hypothesis
Version 1
This version is not peer-reviewed
Potential Natural Compounds for Preventing 2019-nCoV Infection
Version 1
: Received: 28 January 2020 / Approved: 30 January 2020 / Online: 30 January 2020 (03:06:07 CET)
Version 2 : Received: 16 February 2020 / Approved: 18 February 2020 / Online: 18 February 2020 (04:56:54 CET)
Version 3 : Received: 9 March 2020 / Approved: 10 March 2020 / Online: 10 March 2020 (05:09:22 CET)
Version 2 : Received: 16 February 2020 / Approved: 18 February 2020 / Online: 18 February 2020 (04:56:54 CET)
Version 3 : Received: 9 March 2020 / Approved: 10 March 2020 / Online: 10 March 2020 (05:09:22 CET)
How to cite: Chen, H.; Du, Q. Potential Natural Compounds for Preventing 2019-nCoV Infection. Preprints 2020, 2020010358 Chen, H.; Du, Q. Potential Natural Compounds for Preventing 2019-nCoV Infection. Preprints 2020, 2020010358
Abstract
2019-nCoV, a novel coronavirus, caused the pneumonia outbreak in China and continue to expand. The host receptor for 2019-nCoV Angiotensin-converting enzyme 2 (ACE2), which is the same as the host receptor of SARS-CoV. Targeting ACE2 holds the promise for preventing 2019-nCoV infection. Chinese Medicine herbs could be a valuable pool for identifying active compounds for treating infection of 2019-nCoV. In this study, we summarize several active compounds including baicalin, Scutellarin, Hesperetin, Nicotianamine and glycyrrhizin that could have potential anti-2019-nCoV effects, and we conduct molecular docking to predict their capacity for binding ACE2, which may subsequently prevent the 2019-nCoV infection. We propose that these selected compounds worth further investigation for preventing 2019-nCoV.
Keywords
2019-nCov; Baicalin; Scutellarin; Hesperetin; Nicotianamine; Glycyrrhizin
Subject
MEDICINE & PHARMACOLOGY, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)